KR20050085190A - 저온-유도성 발현 벡터 - Google Patents
저온-유도성 발현 벡터 Download PDFInfo
- Publication number
- KR20050085190A KR20050085190A KR1020057009634A KR20057009634A KR20050085190A KR 20050085190 A KR20050085190 A KR 20050085190A KR 1020057009634 A KR1020057009634 A KR 1020057009634A KR 20057009634 A KR20057009634 A KR 20057009634A KR 20050085190 A KR20050085190 A KR 20050085190A
- Authority
- KR
- South Korea
- Prior art keywords
- vector
- protein
- gene
- region
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000013604 expression vector Substances 0.000 title description 12
- 239000013598 vector Substances 0.000 claims abstract description 42
- 230000035772 mutation Effects 0.000 claims abstract description 22
- 108010049152 Cold Shock Proteins and Peptides Proteins 0.000 claims abstract description 11
- 230000008859 change Effects 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 94
- 102000004169 proteins and genes Human genes 0.000 claims description 67
- 125000003729 nucleotide group Chemical group 0.000 claims description 54
- 239000002773 nucleotide Substances 0.000 claims description 53
- 108020004999 messenger RNA Proteins 0.000 claims description 17
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 16
- 239000013600 plasmid vector Substances 0.000 claims description 12
- 238000003780 insertion Methods 0.000 claims description 11
- 230000037431 insertion Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 230000000295 complement effect Effects 0.000 claims description 7
- 238000012217 deletion Methods 0.000 claims description 6
- 230000037430 deletion Effects 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 108020004418 ribosomal RNA Proteins 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 description 56
- 230000014509 gene expression Effects 0.000 description 49
- 239000013612 plasmid Substances 0.000 description 37
- 101150110403 cspA gene Proteins 0.000 description 34
- 241000588724 Escherichia coli Species 0.000 description 32
- 108020003589 5' Untranslated Regions Proteins 0.000 description 29
- 239000012634 fragment Substances 0.000 description 25
- 239000011541 reaction mixture Substances 0.000 description 17
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 12
- 229960000723 ampicillin Drugs 0.000 description 12
- 238000010276 construction Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 239000000499 gel Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 239000008223 sterile water Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011543 agarose gel Substances 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 239000006142 Luria-Bertani Agar Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 101100007857 Bacillus subtilis (strain 168) cspB gene Proteins 0.000 description 4
- 102100026189 Beta-galactosidase Human genes 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 101150049887 cspB gene Proteins 0.000 description 4
- 101150041068 cspJ gene Proteins 0.000 description 4
- 101150068339 cspLA gene Proteins 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000672609 Escherichia coli BL21 Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 101150066555 lacZ gene Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 101150066002 GFP gene Proteins 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 101710137500 T7 RNA polymerase Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 101150026451 csp gene Proteins 0.000 description 2
- 101150096074 cspG gene Proteins 0.000 description 2
- 101150010904 cspLB gene Proteins 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 101150109249 lacI gene Proteins 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000242764 Aequorea victoria Species 0.000 description 1
- 101100018293 Clostridioides difficile pflE gene Proteins 0.000 description 1
- 101710088599 Cold shock-like protein CspLB Proteins 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 101710202013 Protein 1.5 Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101150039316 Ybx3 gene Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 101150008232 csdA gene Proteins 0.000 description 1
- 101150077693 deaD gene Proteins 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000006658 host protein synthesis Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000005312 nonlinear dynamic Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2002-00359956 | 2002-12-11 | ||
| JP2002359956 | 2002-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050085190A true KR20050085190A (ko) | 2005-08-29 |
Family
ID=32500967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057009634A Ceased KR20050085190A (ko) | 2002-12-11 | 2003-12-11 | 저온-유도성 발현 벡터 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7244588B2 (https=) |
| EP (1) | EP1582587B1 (https=) |
| JP (1) | JPWO2004053126A1 (https=) |
| KR (1) | KR20050085190A (https=) |
| CN (1) | CN100379870C (https=) |
| AT (1) | ATE408692T1 (https=) |
| AU (1) | AU2003289023B2 (https=) |
| CA (1) | CA2508808A1 (https=) |
| DE (1) | DE60323678D1 (https=) |
| TW (1) | TW200510534A (https=) |
| WO (1) | WO2004053126A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003216384A1 (en) * | 2002-03-01 | 2003-09-16 | Takara Bio, Inc. | Cold shock inducible expression and production of heterologous polypeptides |
| US8247187B2 (en) * | 2006-08-14 | 2012-08-21 | Biocontrol Systems, Inc. | Method for detecting pathogens |
| WO2024154061A1 (en) * | 2023-01-18 | 2024-07-25 | Pfizer Inc. | Compositions and methods for stabilizing rna |
| AU2024302344A1 (en) * | 2023-06-14 | 2025-12-18 | Pfizer Inc. | Method for stabilizing rna |
| WO2025126071A1 (en) * | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981280A (en) * | 1996-03-22 | 1999-11-09 | The University Of Medicine And Denistry Of New Jersey | Method and constructs for inhibiting protein expression in bacteria |
| US5726039A (en) * | 1994-07-21 | 1998-03-10 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| US5654169A (en) * | 1994-07-21 | 1997-08-05 | Yissum Research & Development Company Of The Hebrew University | Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| ATE377647T1 (de) * | 1997-11-20 | 2007-11-15 | Takara Bio Inc | Durch kälte induzierbarer expressionsvektor |
| EP1053310A1 (en) * | 1998-08-20 | 2000-11-22 | University Of Medicine And Dentistry Of New Jersey | Cold-shock regulatory elements, constructs thereof, and methods of use |
| US6610533B1 (en) * | 2000-03-01 | 2003-08-26 | University Of Medicine And Dentistry Of New Jersey | Cold-shock regulatory elements, constructs thereof, and methods of use |
| AU2003216384A1 (en) * | 2002-03-01 | 2003-09-16 | Takara Bio, Inc. | Cold shock inducible expression and production of heterologous polypeptides |
-
2003
- 2003-12-10 TW TW092134844A patent/TW200510534A/zh not_active IP Right Cessation
- 2003-12-11 KR KR1020057009634A patent/KR20050085190A/ko not_active Ceased
- 2003-12-11 JP JP2004558468A patent/JPWO2004053126A1/ja active Pending
- 2003-12-11 WO PCT/JP2003/015835 patent/WO2004053126A1/ja not_active Ceased
- 2003-12-11 CN CNB200380109675XA patent/CN100379870C/zh not_active Expired - Fee Related
- 2003-12-11 AU AU2003289023A patent/AU2003289023B2/en not_active Ceased
- 2003-12-11 DE DE60323678T patent/DE60323678D1/de not_active Expired - Lifetime
- 2003-12-11 US US10/538,793 patent/US7244588B2/en not_active Expired - Fee Related
- 2003-12-11 AT AT03778794T patent/ATE408692T1/de not_active IP Right Cessation
- 2003-12-11 CA CA002508808A patent/CA2508808A1/en not_active Abandoned
- 2003-12-11 EP EP03778794A patent/EP1582587B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004053126A1 (ja) | 2004-06-24 |
| EP1582587B1 (en) | 2008-09-17 |
| EP1582587A1 (en) | 2005-10-05 |
| ATE408692T1 (de) | 2008-10-15 |
| TWI316091B (https=) | 2009-10-21 |
| TW200510534A (en) | 2005-03-16 |
| AU2003289023A1 (en) | 2004-06-30 |
| EP1582587A4 (en) | 2006-10-25 |
| CN100379870C (zh) | 2008-04-09 |
| CA2508808A1 (en) | 2004-06-24 |
| US7244588B2 (en) | 2007-07-17 |
| DE60323678D1 (de) | 2008-10-30 |
| US20060148033A1 (en) | 2006-07-06 |
| CN1748027A (zh) | 2006-03-15 |
| JPWO2004053126A1 (ja) | 2006-04-13 |
| AU2003289023B2 (en) | 2008-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100355963B1 (ko) | 영양요구성을 보완함으로써 항생제 없이 선별되는 원핵세포 숙주/벡터 시스템 | |
| EP0885967B1 (en) | Chaperone expression plasmids | |
| CA2619989C (en) | Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria | |
| JP5808671B2 (ja) | 機能グループｉｉ莢膜遺伝子クラスターを有しないｅ．ｃｏｌｉｂｌ２１株 | |
| KR100596071B1 (ko) | 저온 유도성 발현벡터 | |
| CN108220288B (zh) | 一种聚核苷酸、转化子及其应用 | |
| JPWO1999027117A1 (ja) | 低温誘導発現ベクター | |
| KR20050085190A (ko) | 저온-유도성 발현 벡터 | |
| JP3783963B2 (ja) | ポリペプチドの改善された組換え的産生方法 | |
| JPS63233790A (ja) | 細菌中に含まれるプラスミドの安定化方法及びこれにより得られる菌株 | |
| US5654169A (en) | Vectors and transformed host cells for recombinant protein production at reduced temperatures | |
| Sandler et al. | Factors affecting expression of the recF gene of Escherichia coli K-12 | |
| JP4370353B2 (ja) | Ｄｎａ及びかかるｄｎａを用いた低温での目的蛋白質の発現方法 | |
| JP3793812B2 (ja) | 低温での組み換えタンパク質の発現に適した新規発現ベクター | |
| JP4053572B2 (ja) | 低温誘導発現プロモーター及びかかるプロモーターを含有する低温誘導発現ベクター | |
| WO2007039632A1 (en) | Novel selection system | |
| WO2017163946A1 (ja) | 誘導型プロモーター | |
| KR101419214B1 (ko) | LacI 단백질 변이체를 이용한 독성 단백질의 생산 방법 | |
| Sun et al. | Domain analysis of the Edwardsiella tarda ferric uptake regulator | |
| Rasmussen et al. | An Intramolecular Upstream Helix Ensures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050527 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060825 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20070619 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20070912 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20070619 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |